GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Policy Acquisition Expense

Renalytix (LSE:RENX) Policy Acquisition Expense


View and export this data going back to 2018. Start your Free Trial

What is Renalytix Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Renalytix (LSE:RENX) Business Description

Traded in Other Exchanges
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.